Document is current
Any future updates will be listed below
-
Authors
Le Clerc, Sigrid
Lombardi, Laura
Baune, Bernhard T.
Amare, Azmeraw T.
Schubert, Klaus Oliver
Hou, Liping
Clark, Scott R.
Papiol, Sergi
Cearns, Micah
Heilbronner, Urs
Degenhardt, Franziska
Tekola-Ayele, Fasil
Hsu, Yi-Hsiang
Shekhtman, Tatyana
Adli, Mazda
Akula, Nirmala
Akiyama, Kazufumi
Ardau, Raffaella
Arias, Bárbara
Aubry, Jean-Michel
Backlund, Lena
Bhattacharjee, Abesh Kumar
Bellivier, Frank
Benabarre, Antonio
Bengesser, Susanne
Biernacka, Joanna M.
Birner, Armin
Brichant-Petitjean, Clara
Cervantes, Pablo
Chen, Hsi-Chung
Chillotti, Caterina
Cichon, Sven
Cruceanu, Cristiana
Czerski, Piotr M.
Dalkner, Nina
Dayer, Alexandre
Del Zompo, Maria
DePaulo, J. Raymond
Étain, Bruno
Jamain, Stephane
Falkai, Peter
Forstner, Andreas J.
Frisen, Louise
Frye, Mark A.
Fullerton, Janice M.
Gard, Sébastien
Garnham, Julie S.
Goes, Fernando S.
Grigoroiu-Serbanescu, Maria
Grof, Paul
Hashimoto, Ryota
Hauser, Joanna
Herms, Stefan
Hoffmann, Per
Jiménez, Esther
Kahn, Jean-Pierre
Kassem, Layla
Kuo, Po-Hsiu
Kato, Tadafumi
Kelsoe, John R.
Kittel-Schneider, Sarah
Ferensztajn-Rochowiak, Ewa
König, Barbara
Kusumi, Ichiro
Laje, Gonzalo
Landén, Mikael
Lavebratt, Catharina
Leckband, Susan G.
Tortorella, Alfonso
Manchia, Mirko
Martinsson, Lina
McCarthy, Michael J.
McElroy, Susan L.
Colom, Francesc
Millischer, Vincent
Mitjans, Marina
Mondimore, Francis M.
Monteleone, Palmiero
Nievergelt, Caroline M.
Nöthen, Markus M.
Novák, Tomas
O’Donovan, Claire
Ozaki, Norio
Ösby, Urban
Pfennig, Andrea
Potash, James B.
Reif, Andreas
Reininghaus, Eva
Rouleau, Guy A.
Rybakowski, Janusz K.
Schalling, Martin
Schofield, Peter R.
Schweizer, Barbara W.
Severino, Giovanni
Shilling, Paul D.
Shimoda, Katzutaka
Simhandl, Christian
Slaney, Claire M.
Pisanu, Claudia
Squassina, Alessio
Stamm, Thomas
Stopkova, Pavla
Maj, Mario
Turecki, Gustavo
Vieta, Eduard
Veeh, Julia
Witt, Stephanie H.
Wright, Adam
Zandi, Peter P.
Mitchell, Philip B.
Bauer, Michael
Alda, Martin
Rietschel, Marcella
McMahon, Francis J.
Schulze, Thomas G.
Spadoni, Jean-Louis
Boukouaci, Wahid
Richard, Jean-Romain
Le Corvoisier, Philippe
Barrau, Caroline
Zagury, Jean-François
Leboyer, Marion
Tamouza, Ryad
-
Funding
Funding for this research was provided by:
FRM (FDM202006011305)
- License Information
-
More Information
Article History
Received: 24 March 2021
Accepted: 13 August 2021
First Online: 8 September 2021
Competing interests
: The authors declare that they have no competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. MAd has received a grant from Servier, speaker’s fees from Servier, Lundbeck, Aristo, Parexel, Gilead, ViiV, Deutsche Bank, MSD, and MyTomorrows, plus a non-fi nancial support from Lundbeck. KA has received speaker’s fees from Taisho Toyama Pharmaceutical. MAl is funded by a grant of the Canadian Institutes of Health Research. MB has received speaker’s fees from AstraZeneca, Pfi zer, Lilly, Lundbeck, GlaxoSmithKline, Servier, and Ferrer Internacional. BÉ received non-financial support from Labex Biopsy and Fondation Fondamental. RH received grants and speaker honoraria from Dainippon Sumitomo Pharma and Novartis plus speaker honoraria from Eli Lilly Japan, GlaxoSmithKline, Hisamitsu Pharmaceutical, Janssen Pharmaceutical, Nippon Zoki Pharmaceutical, Otsuka Pharmaceutical, Astellas Pharma, Pfi zer, and the Yoshitomiyakuhin Corporation. TK received a grant from Takeda Pharmaceutical and fees from Kyowa Hakko Kirin, Eli Lilly Japan, Otsuka Pharmaceutical, GlaxoSmithKline, Taisho Toyama Pharmaceutical, Dainippon Sumitomo Pharma, Meiji Seika Pharma, Pfi zer Japan, Mochida Pharmaceutical, Shionogi & Co, Janssen Pharmaceutical, Yoshitomiyakuhin Corporation, Agilent Technologies, Astellas Pharma, and Wako Pure Chemical Industries. IK received grants and fees from Dainippon Sumitomo Pharma, Eisai, Eli Lilly, GlaxoSmithKline, Kyowa Hakko Kirin, Meiji Seika Pharma, MSD, Novartis, Otsuka, Ono Pharmaceutical, Pfi zer, Tanabe Mitsubishi Pharma, Takeda Pharmaceutical, Shionogi, and Yoshitomi Pharmaceutical; he received grants from AbbVie GK, Asahi Kasei Pharma, Boehringer Ingelheim, Chugai Pharmaceutical, and Daiichi Sankyo and fees from Astellas Pharma and Janssen Pharmaceutical. MJM served as unpaid consultant for Pathway Genomic (San Diego, USA). SLM received a grant and fees from Naurex and Shire, further grants from Alkermes, Cephalon, Forest, Marriott Foundation, Orexigen Therapeutics, and Takeda Pharmaceutical, he further has served on the advisory boards for Bracket, Hoff mann-La Roche, MedAvante, Sunovion and received fees from Novo Nordisk. PRS received a grant from NHMRC. TGS received a grant and fees from Roche Pharmaceuticals. TSt received personal fees from Servier, Lundbeck, and Bristol-Myers Squibb. EV has received grants and served as consultant, advisor or CME speaker for the following entities (unrelated to the present work): AB-Biotics, Abbott, Allergan, Angelini, Dainippon Sumitomo Pharma, Ferrer, Gedeon Richter, GH Research, Janssen, Lundbeck, Otsuka, Sage, Sanofi-Aventis, and Takeda. FC In the last two years he has served as a speaker or in the advisory board of the following companies: Abott, Sandoz and Sanofi and he receives unrestricted research support from Telefónica Alpha. JRDP was an unpaid consultant for Assurex Health on behalf of the National Network of Depression Centers and he owns stock in CVS. All above listed interests are outside of the submitted work. All other authors declare no competing interests.
